July 28, 2014 1:54 AM ET

Pharmaceuticals

Company Overview of Javelin Pharmaceuticals, Inc.

Company Overview

Javelin Pharmaceuticals, Inc. researches, develops, and commercializes treatments for the relief of moderate to severe pain primarily in the United States and Europe. Its product line primarily includes Dyloject, an injectable diclofenac; Ereska, an intranasal ketamine; and Rylomine, an intranasal morphine that completed the phase III development stage. The company offers its products for treating various pain disorders, such as acute and episodic moderate-to-severe pain associated with breakthrough cancer pain; post-operative pain; and post-trauma pain, such as orthopedic injury pain, procedural pain, and burn pain. It has license agreements with Shimoda Biotech, Ltd. to develop and commerc...

125 CambridgePark Drive

Cambridge, MA 02140

United States

Founded in 1998

21 Employees

Phone:

617-349-4500

Fax:

617-349-4505

Key Executives for Javelin Pharmaceuticals, Inc.

President
Age: 65
European Managing Director
Senior Vice President of Devices
Manager of Corporate Communications
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Mayne Pharma (USA), Inc. United States
SKS Ocular, LLC United States
Stencor, Inc. United States
Housey Pharmaceutical Research Laboratories LLC United States
Canchew Biotechnologies LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Javelin Pharmaceuticals, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.